Escalate With Intention: Stepwise, Target-Anchored Moves
Christyn Edmundson, MD
Gil I. Wolfe MD, FAAN
The IgG Clock: Redose Using IgG Kinetics
Minimal By Design: Define MSE Endpoints
FcRn: Same Class, Different Paths—Spot Agent Differentiators
Turning Flares Into Function: Flag Uncontrolled Disease
Target Locked in gMG: Why T2T Matters
Precision Starts Before Birth: Reimagining Fetal Care Through FcRn Immune Modulation
Kenneth J. Moise Jr., MD
Kara B. Markham, MD
Primary Biliary Cholangitis: Shining Light on an "Invisible" Female Health Burden
Gideon Hirschfield, MB, BChir, PhD
Marlyn Mayo, MD
Diagnosing and Treating IBS: It Begins With One Simple Question
Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE
Kimberly D. Orleck, PA-C
Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT): Overcoming Diagnostic and Therapeutic Challenges
Karin J. Blakemore, MD
Emilie L. Vander Haar
Clinical Considerations for the Diagnosis of Endometriosis
Linda Bradley, MD
James A. Simon, MD, CCD, NCMP, IF, FACOG
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
Sawsan As-Sanie, MD
The Integral Role of GnRH Antagonists in the Management of Endometriosis
Changing the Mindset in the Management of Endometriosis: Hitting the Pause Button on Surgical Procedures and Expanding the Role of GnRH Antagonists
Lee P. Shulman, MD, FACMG, FACOG
Melissa Simon, MD
Samantha Denäe
Casey Joe Hinds
Strategies to Address Healthcare Disparities in Patients With Endometriosis
Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
Roberto Romero, MD, DMedSci
Loading...
We're glad to see you're enjoying Omnia Education… but how about a more personalized experience?
Press cancel to remain on Omnia Education. Press the link below or the continue button to keep going.